MedTrace Logo

Use of Biomaterials as Desensitizer Agents

NCT02770573 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-04-20

No results posted yet for this study

Summary

Aim: to investigate the clinical effectiveness over 12 weeks of three different biomaterials, nano-hydroxyapatite based, in the therapy of the dental sensitivity.

Methods: The study is designed as a randomized clinical trial comparing: 1) Cavex Bite\&White ExSense, 2) Teethmate™ Desensitizer , 3) Ghimas Dentin Desensitizer. The pain experience was generated by a cold stimulus directly to a sensitive tooth surface and assessed using the Visual Analogue Scale (VAS). The response was recorded before the application of the materials (PRE-1), immediately after (POST-1), at 1-week (POST-2), 4-weeks (POST-3) and 12-week controls (POST-4).

Conditions

  • Dentin Sensitivity

Interventions

OTHER

Cavex Bite&White ExSense

a water-based mint aroma gel containing hydroxyapatite and potassium nitrate.

OTHER

Kuraray Teethmate™ Desensitizer

Calcium-Phosphate-based powder and a liquid mainly water-based.

OTHER

Ghimas Dentin Desensitizer

a fluid desensitizing gel with 30% of nano-hydroxyapatite, added to 70:100 thousandths of micron-sized crystals of nano- hydroxyapatite.

Sponsors & Collaborators

  • Università degli Studi di Sassari

    lead OTHER

Principal Investigators

  • Egle Milia, Prof · Università degli Studi di Sassari

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-06-30
Completion
2017-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02770573 on ClinicalTrials.gov